v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,498 $ 1,413
Marketable securities 3,981 3,595
Trade and other receivables, net 342 282
Loans and merchant cash advances, net 1,224 816
Other current assets 209 169
Total current assets 7,254 6,275
Long-term assets    
Property and equipment, net 47 49
Operating lease right-of-use assets, net 93 98
Intangible assets, net 22 29
Deferred tax assets 37 44
Other long-term assets 21 0
Long-term investments 709 115
Equity and other investments ($3,930 and $2,977, carried at fair value) 4,647 3,482
Equity method investment 642 780
Goodwill 452 427
Total long term assets 6,670 5,024
Total assets 13,924 11,299
Current liabilities    
Accounts payable and accrued liabilities 737 579
Deferred revenue 283 302
Operating lease liabilities 18 17
Convertible senior notes 918 0
Total current liabilities 1,956 898
Long-term liabilities    
Deferred revenue 147 196
Operating lease liabilities 190 217
Convertible senior notes 0 916
Deferred tax liabilities 73 6
Total long term liabilities 410 1,335
Commitments and contingencies (Note 17)
Shareholders’ equity    
Common stock, unlimited Class A subordinate voting shares authorized, 1,215,229,233 and 1,207,318,947, issued and outstanding; unlimited Class B restricted voting shares authorized, 79,350,906 and 79,251,346 issued and outstanding; 1 Founder share authorized, 1 and 1 issued and outstanding 9,634 9,201
Additional paid-in capital 305 251
Accumulated other comprehensive (loss) income (10) 4
Accumulated surplus (deficit) 1,629 (390)
Total shareholders’ equity 11,558 9,066
Total liabilities and shareholders’ equity $ 13,924 $ 11,299